Status:

COMPLETED

Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II

Lead Sponsor:

Medical University of Vienna

Conditions:

Cervical Intraepithelial Neoplasia

Eligibility:

FEMALE

18-60 years

Phase:

PHASE2

Brief Summary

The investigators want to test whether treatment with a natural progesterone intravaginally increases the cure rate of cervical intraepithelial neoplasia grade I and II.

Detailed Description

Background: 1. The development of cervical intraepithelial neoplasia (CIN) was linked to a decreased local immune response as evidenced by a decrease of Langerhans' cell (LC) count in the cervical ep...

Eligibility Criteria

Inclusion

  • Histological evidence of CIN I and II
  • Transformation zone and lesion margins fully visible
  • Compliant subject
  • Safe contraception
  • Negative pregnancy test

Exclusion

  • Lesion related
  • CIN III, (micro)-Invasive Cancer
  • Endocervical lesion, upper margin of lesion not visible on colposcopy
  • Non-compliance of patient
  • PAP V
  • Drug related
  • Age \> 60
  • Hypersensitivity to progesterone or any component of the formulation
  • Thrombophlebitis
  • Undiagnosed vaginal bleeding
  • Carcinoma of the breast
  • Cerebral apoplexy
  • Severe liver dysfunction
  • Pregnancy
  • Depression
  • Diabetes
  • Epilepsy
  • Migraine
  • Renal dysfunction
  • Asthma
  • HIV infection
  • Hepatitis B or C
  • Concurrent use of anticoagulants
  • Uncontrolled hypertension (\> 160/90 mmHg)
  • Breast cancer in personal history
  • Concurrent hormonal therapy including OC
  • Clinical laboratory related
  • Hemoglobin \< 11 g/dl
  • Leukocytes \< 4,0 x 109/L
  • Platelet count \< 100 x 109/L
  • Serum bilirubin \> 2 x above upper cut-off value
  • Serum GOT \> 2 x above upper cut-off value
  • Serum GPT \> 2 x above upper cut-off value
  • Serum alkaline phosphatase \> 2 x above upper cut-off value
  • Serum creatinine \> 2 x above cut-off value

Key Trial Info

Start Date :

August 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2010

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00247169

Start Date

August 1 2004

End Date

April 1 2010

Last Update

March 9 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dept OB/GYN, Med University of Vienna

Vienna, Austria

Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II | DecenTrialz